PH25728A - Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type - Google Patents

Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Info

Publication number
PH25728A
PH25728A PH37078A PH37078A PH25728A PH 25728 A PH25728 A PH 25728A PH 37078 A PH37078 A PH 37078A PH 37078 A PH37078 A PH 37078A PH 25728 A PH25728 A PH 25728A
Authority
PH
Philippines
Prior art keywords
antigestagen
trilostane
synthesis inhibitor
progesteron
combined use
Prior art date
Application number
PH37078A
Inventor
Walter Dr Elger
Sybille Dr Beir
Beate Kosub
Marrianne Fanrich
Of Dr Krzysztof Dr Chwalisz
Gordon Dr Oliver
Original Assignee
Schering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering filed Critical Schering
Publication of PH25728A publication Critical patent/PH25728A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The medicine contains a progesterone synthesis inhibitor (ProH) of the trilostane or epostane type and an antigestagen (AG) and is used for inducing labour at term in humans and animals and for terminating normal or pathological pregnancy. The combination according to the invention is also suitable for treating hormone-dependent tumours, endometriosis and dysmenorrhoea.
PH37078A 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type PH25728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (en) 1987-06-16 1987-06-16 PROGESTERONE SYNTHESIS INHIBITOR AND ANTI-STAGE TO BEGINNING BIRTH OR FOR PREGNANCY

Publications (1)

Publication Number Publication Date
PH25728A true PH25728A (en) 1991-10-18

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37078A PH25728A (en) 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Country Status (12)

Country Link
EP (1) EP0296097B1 (en)
JP (1) JP2716461B2 (en)
AT (1) ATE94391T1 (en)
AU (1) AU611160B2 (en)
CA (1) CA1318251C (en)
DE (2) DE3720420A1 (en)
DK (1) DK327288A (en)
ES (1) ES2059556T3 (en)
IE (1) IE63453B1 (en)
IL (1) IL86731A (en)
PH (1) PH25728A (en)
ZA (1) ZA884315B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3522753B2 (en) * 1992-09-25 2004-04-26 バーンズ，クライブ Prevention of deposition of pollutants in beer lines
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
AU611160B2 (en) 1991-06-06
DK327288D0 (en) 1988-06-15
IL86731A (en) 1992-11-15
DE3884067D1 (en) 1993-10-21
DE3720420A1 (en) 1988-12-29
DK327288A (en) 1988-12-17
CA1318251C (en) 1993-05-25
EP0296097B1 (en) 1993-09-15
ES2059556T3 (en) 1994-11-16
IL86731A0 (en) 1988-11-30
ATE94391T1 (en) 1993-10-15
EP0296097A3 (en) 1990-04-04
JPS63316725A (en) 1988-12-26
IE63453B1 (en) 1995-04-19
ZA884315B (en) 1989-06-28
IE881804L (en) 1988-12-16
AU1775088A (en) 1988-12-22
EP0296097A2 (en) 1988-12-21
JP2716461B2 (en) 1998-02-18

Similar Documents

Publication Publication Date Title
GB2102287B (en) Use of aromatase-inhibitors with antiandrogens for treatment of prostatic hyperplasia.
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
DK37388D0 (en) Steroid 5-alpha-reductase inhibitors
NZ256681A (en) Tablet containing ranitidine (or its salt), chewable base, and flavouring; the tablet is free of alginic acid with sodium bicarbonate
JPS5413651A (en) House ventilating device
PH25728A (en) Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type
ZA857721B (en) Process for treatment of rheumatic diseases
JPS5431952A (en) Temperature controller
NO883743D0 (en) PROCEDURE AND DEVICE FOR AA GIVING PERSONAL AIR CONDITION ("AIR CONDITION").
JPS51113435A (en) Offering processor
JPS51141279A (en) Method of improving physical constitution of cattle
EP0151385A3 (en) Use of phytosterolglycosides for the treatment of elevated 5(6) alpha-epoxycholesterol levels
ES451701A1 (en) 6{62 ,17-Dihydroxy-7{60 -(lower alkoxy)carbonyl-3-oxo-17{60 -pregn-4-ene-21-carboxylic acid {65 -lactones and congeners
IE810158L (en) Control of ovulation in animals.
JPS51150940A (en) Cashless card and cashless system
ZA873127B (en) Method of regulating animal reproduction
JPS5413648A (en) Indoor temperature controller system
JPS51143224A (en) Car driving device for physically handicapped person
Jamail The impostor phenomenon and high-achieving men and women issues of sex and self-perceived atypicality.
JPS5235017A (en) Train control system
JPS53110440A (en) Prevention system for competition between processors
Gallagher The hubris of philosophy: Alcibiades' praise of Socrates in Plato's Symposium
JPS5319099A (en) Commutation ticket issuing apparatus
World Health Organization Indicators and methods for evaluating the effectiveness of health interventions: an initial review
Ames The comparison of femoral fracture repair in young calves